Please login to the form below
AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
Healthcare comms company wins recognition for second year in a row
Celgene’s Revlimid scores NICE approval in follicular lymphoma
New ‘chemotherapy-free’ treatment for patients with limited options
Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC
Advisory committee voted 6-5 in favour of drug
Menlo slumps as itching drug fails mid-stage trial
Shares in US biotech closed down almost a third after announcement
Trial of Amgen, Servier’s heart failure drug clears interim check
Drug could become a $2bn product if approved
Mallinckrodt reaches tentative $1.6bn opioid settlement
Agreement reached with a plaintiff's executive committee
Takeda buys coeliac disease partner PvP Biologics after phase 1 win
Deal includes upfront payment plus up to $330m in milestones
IMV preps pivotal trials for ovarian cancer T cell therapy
Drug stabilised disease in 79% of 19 evaluable patients
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US
National Institutes of Health initiates trial of experimental drug
Q&A: Stefi Rucci
PME interviews SAY Communications' joint MD and Director of Healthcare
-
Q&A: Emma SergeantPME interviews president of the DAS Group of Companies in Europe
-
Q&A: Vicky BramhamPME interviews OPEN Health Patient & Brand Communications' managing director, PR
-
Moderna and GSK advance coronavirus vaccine candidatesDevelopments come amid rapidly growing cases across the globe
-
FDA accepts review to broaden GSK’s Zejula label Seeks approval in advanced ‘all-comer’ ovarian cancer population
-
Sanofi says it will spin out active ingredient business by 2022New chief exec Paul Hudson continues revamp
-
Coronavirus outbreak escalation could impact drug supply chain Concerns raised that the virus could cause shortages
-
Roche’s Herceptin/Perjeta fixed-dose combo filed with FDAFinal decision due by 18 October
-
As new coronavirus outbreaks emerge, fears of a global pandemic escalateIncreased quarantine measures are reported across the globe
-
Lilly’s Trulicity scores CV reduction indication in the USApproved for risk reduction in primary and secondary populations
Latest appointments
-
AVENIR GLOBAL appoints global healthcare leadMirandi Dini expands role at communications firm
-
Bedrock Group bolsters team with three key appointmentsAndy Jobson, Deborah Blain and Vicky O'Connor join company
-
Ex-BMS exec jumps to Gilead to lead research group Gilead appoints Michael Quigley to lead research team
-
Porterhouse announces members of medical advisory groupGroup provides first-hand clinical experience to colleagues and clients
-
Porter Novelli adds Amber Tovey to London health team Tovey joins the team as business director
Featured jobs
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
-
Account Director
-
£Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Account Manager (PR)
-
Great Benefits
-
Senior External Communications Lead
-
£Competitive Salary
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Publications director
-
Competitive salary and bonus scheme
Subscribe to our email news alerts
- Immutep spikes on trial of its LAG-3 drug with Keytruda
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Coronavirus outbreak escalation could impact drug supply chain
- Researchers discover new antibiotic using AI
- Genital herpes vaccine candidate heads for human studies
- Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
- AVENIR GLOBAL appoints global healthcare lead
- Bedrock Group bolsters team with three key appointments
- AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC
- Menlo slumps as itching drug fails mid-stage trial
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- The ALS patient journey
- Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
- Equipping your medical affairs teams with solutions to navigate the healthcare landscape
- Dr Tyler Ray, OPEN Health Medical Communications...
- Can protein degraders unlock ‘undruggable’ drug targets?
- Exploring a new and exciting area of small-molecule drug discovery...
Quick links
Infographics
